TY - JOUR
T1 - Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans
AU - Yang, Eric H.
AU - McConnell, Joseph P.
AU - Lennon, Ryan J.
AU - Barsness, Gregory W.
AU - Pumper, Geralyn
AU - Hartman, Stacy J.
AU - Rihal, Charanjit S.
AU - Lerman, Lilach O.
AU - Lerman, Amir
PY - 2006/1
Y1 - 2006/1
N2 - Objective - The purpose of the current study was to determine whether lipoprotein-associated phospholipase A2 (Lp-PLA2) is associated with coronary endothelial dysfunction and is a predictor of endothelial dysfunction in humans. Methods and Results - Patients (172) with no significant coronary artery disease (<30% stenosis) undergoing assessment of coronary endothelial function were studied. Endothelial function was assessed by the change in coronary blood flow and coronary artery diameter in response to intracoronary acetylcholine. Plasma concentrations of Lp-PLA2 were measured, and patients were divided into tertiles. Patients in tertiles 2 and 3 had a significantly lower change in coronary blood flow (63.8±73.2 and 32.0±71.7 versus 78.4±73.2%; P<0.001) and greater epicardial coronary artery vasoconstriction (-14.1±14.7 and -23.3±25.1 versus -9.5±15.2% mean diameter change; P<0.001) in response to acetylcholine. Patients with coronary endothelial dysfunction had significantly higher serum concentrations of Lp-PLA2 than those with normal endothelial function (246.2±71.6 versus 209±56.7 ng/mL; P=0.001). The odds ratio for coronary endothelial dysfunction in patients with Lp-PLA 2 in the highest tertile was 3.3 (95% CI, 1.6 to 6.6). Conclusions - Lp-PLA2 is independently associated with coronary artery endothelial dysfunction and is a strong predictor of endothelial dysfunction in humans.
AB - Objective - The purpose of the current study was to determine whether lipoprotein-associated phospholipase A2 (Lp-PLA2) is associated with coronary endothelial dysfunction and is a predictor of endothelial dysfunction in humans. Methods and Results - Patients (172) with no significant coronary artery disease (<30% stenosis) undergoing assessment of coronary endothelial function were studied. Endothelial function was assessed by the change in coronary blood flow and coronary artery diameter in response to intracoronary acetylcholine. Plasma concentrations of Lp-PLA2 were measured, and patients were divided into tertiles. Patients in tertiles 2 and 3 had a significantly lower change in coronary blood flow (63.8±73.2 and 32.0±71.7 versus 78.4±73.2%; P<0.001) and greater epicardial coronary artery vasoconstriction (-14.1±14.7 and -23.3±25.1 versus -9.5±15.2% mean diameter change; P<0.001) in response to acetylcholine. Patients with coronary endothelial dysfunction had significantly higher serum concentrations of Lp-PLA2 than those with normal endothelial function (246.2±71.6 versus 209±56.7 ng/mL; P=0.001). The odds ratio for coronary endothelial dysfunction in patients with Lp-PLA 2 in the highest tertile was 3.3 (95% CI, 1.6 to 6.6). Conclusions - Lp-PLA2 is independently associated with coronary artery endothelial dysfunction and is a strong predictor of endothelial dysfunction in humans.
KW - Endothelial function
KW - Inflammatory markers
KW - Lipoprotein-associated phospholipase A
UR - http://www.scopus.com/inward/record.url?scp=33644830673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644830673&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.0000191655.87296.ab
DO - 10.1161/01.ATV.0000191655.87296.ab
M3 - Article
C2 - 16239595
AN - SCOPUS:33644830673
SN - 1079-5642
VL - 26
SP - 106
EP - 111
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 1
ER -